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Background. Socioeconomic deprivation may be an important determinant of dementia risk, 
mortality, and access to diagnostic services. Premature mortality from other causes and 
under-representation of deprived individuals in research may lead to this effect being 
overlooked. 
Methods. We obtained Office of National Statistics (ONS) mortality data for England and 
Wales from 2001 to 2017, stratified by age, diagnosis code and UK Index of Multiple 
Deprivation (IMD) decile. We used standardised mortality ratios (SMR) and a Poisson model 
to compare likelihood of dying from dementia in each IMD decile. We also examined the 
associations of deprivation with age at death from dementia, and with likelihood of receiving 
a diagnosis of unspecified dementia. 
Findings. Risk of dying from dementia was higher in more deprived deciles (Mean SMR 
[95%CI] in decile 1: 0.528 [0.506 to 0.550], decile 10: 0.369 [0.338 to 0.400]). In 2017, 
14,837 excess dementia deaths were attributable to deprivation (21.5% of all dementia 
deaths that year). There were dose-response associations of deprivation with likelihood of 
being older at death with dementia (odds ratio [95%CI] for decile 10 (least deprived): 1.31 
[1.28 to 1.33] relative to decile 1), and with likelihood of receiving a diagnosis of unspecified 
dementia (odds ratio [95%CI] for decile 10: 0.78 [0.76 to 0.80] relative to decile 1). 
Conclusion. Socioeconomic deprivation in England and Wales is associated with increased 
dementia mortality, younger age at death with dementia, and poorer access to specialist 






Persistent and widening socioeconomic inequality in the United Kingdom is associated with 
negative health outcomes including excess premature mortality in those who are more 
deprived(1). However, the association of this with dementia mortality across the United 
Kingdom has not been systematically examined. 
Socioeconomic deprivation has previously been shown to be a risk factor for dementia(2-6). 
Various factors have been hypothesised to mediate this relationship, including cognitive 
reserve, education, diet, vascular risk factors, stress and access to healthcare(7). Deprivation 
is closely linked to education, which has been more widely studied as a risk factor for 
dementia, but some evidence suggests that wealth and area-based indices of deprivation 
may be more important than education when all are taken into account(8, 9). Deprivation has 
also been associated with earlier death from dementia and with reduced access to good 
dementia care(10, 11). 
There are obstacles to examining the effect of deprivation on dementia outcomes, and its 
importance as a risk factor is therefore often overlooked(8). Cohort studies tend to under-
represent more deprived participants, while in population studies survival bias and 
incomplete ascertainment of cases in more deprived groups due to healthcare inequalities 
may lead to underestimation of the influence of deprivation(12-16). 
We used nationwide death certificate data from all of England and Wales during a 17-year 
period from 2001 to 2017. Deprivation was measured using the Index of Multiple Deprivation 
(IMD). The primary aim of the study was to test the hypothesis that age-standardised 
mortality from dementia would be higher in more deprived deciles, and that this effect would 
become greater over time due to disproportionate improvements in ascertainment in the 
more deprived deciles. Furthermore, we hypothesised that those dying of dementia would be 
younger on average in more deprived deciles. Finally, we hypothesised that more deprived 
 5 
deciles would be more likely to have an unspecified dementia diagnosis (as opposed to any 





Mortality data were obtained from the Office for National Statistics (ONS). A search of 
dementia deaths was conducted to obtain data between 2001-2017 (from the start of ICD-10 
coding to the latest year available at the time of data access), for those aged 65 and over in 
England and Wales where dementia was listed as a cause of death according to ONS coding 
algorithms (either listed as an underlying cause of death or mentioned on the death certificate 
where the cause of death was listed as chest infection or aspiration pneumonia). The lower 
age limit of 65 was chosen because this is the standard age used to dichotomise early and 
late onset dementia. Below this age, dementia is much more likely to be genetic in aetiology, 
less likely to be influenced by life course factors, and the numbers of deaths are very small 
resulting in imprecise mortality ratio estimates. The number of deaths were split by age group 
(65-69; 70-74; 75-79; 80-84; 85-89; 90+), Index of Multiple Deprivation (IMD) decile (1: most 
deprived), year and specific dementia type at death (Alzheimer’s disease; Unspecified 
dementia; Vascular dementia; Other specified dementia), according to the ICD-10 code. A full 
list of ICD-10 codes and their diagnostic groupings is available in Supplementary Table 1. The 
population size for each age band and IMD decile, per year, was also obtained from the ONS. 
We were thus able to partly mitigate the influence of premature mortality from other causes by 
adjusting for surviving population size within each IMD decile in each year. 
 
Defining deprivation 
Deprivation was measured using the UK Index of Multiple Deprivation (IMD). This is an area-
based measure of socioeconomic status that ranks every lower-layer super output area 
(LSOA; a small geographical area with on average 1500 inhabitants) in England and Wales, 
taking into account seven domains of deprivation: income, employment, education, health, 
crime, barriers to housing and services, and living environment. Each LSOA is then assigned 




Association of deprivation with dementia mortality 
Population size was aggregated across age bands and the number of deaths across age 
bands and dementia type. Mortality rates were calculated for each IMD-year level. IMD decile 
1 (most deprived decile) in 2017 was used as the reference category and the standardised 
mortality ratio (SMR) was calculated for all levels. As we wished to model the effect of IMD on 
SMR over time, linear models are not appropriate for this data, given the non-linear 
relationship between time and SMR for each IMD decile. Instead we used a generalised 
additive model (GAM), which uses smoothing functions to model non-linear relationships. In 
our case we modelled year as a smooth term. We calculated excess deaths attributable to 
deprivation in 2017 by determining the expected deaths in each IMD decile based on the SMR 
for decile 10, and then subtracting this from the observed number of deaths. We additionally 
fitted a Poisson model with number of deaths as the response, IMD decile and age group as 
independent variables, and person-years as an offset in order to model the association of 
deprivation with incident risk of dying from dementia during the 17 year period. 
 
Association of deprivation with age at death 
In order to examine the effect of IMD on age at death from dementia, the number of deaths 
due to dementia was aggregated across year and dementia type, as were the population sizes 
within these strata. We used an ordinal logistic regression model to determine the effect of 
IMD on age at death with dementia, expressed as the cumulative odds of being in any older 
age group at death. For each decile, the percentage of deaths from that decile that occurred 
in each age-group was also calculated.  
 
Association of deprivation with dementia diagnosis 
In order to examine the effect of IMD on whether the subtype of dementia at death was 
specified or not (a proxy for access to appropriate specialist care(17), the number of deaths 
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was aggregated across age and year, and categorised as unspecified dementia or any 
specified dementia. We used a logistic regression model to determine the effect of deprivation 
on the odds of having a diagnosis of unspecified dementia versus any specified dementia 
diagnosis.  
 
Analyses were conducted using R (version 3.6.2). 
 
Data Availability 
All data are publicly available from the Office of National Statistics: https://www.ons.gov.uk   
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Results 
There were 578,623 recorded deaths due to dementia from 2001-2017 in England and 
Wales, with an overall mortality rate of 3.69 per 1000 people over the age of 65. 351,438 
(61%) of dementia deaths were recorded as unspecified dementia, whereas only 137,477 
(24%) deaths were recorded as being due to Alzheimer’s disease. The total number of 
deaths recorded by year, deprivation decile, dementia type and age-group are available in 
Supplementary Table 2. 
 
Association of deprivation with dementia mortality 
In general, the SMR increased over time, with higher standardised mortality in more 
deprived deciles (Figure 1). There was a marked increase in mortality between 2010 and 
2011 (median increase in SMR=0.19 across deprivation deciles, range 0.16 to 0.24) and a 
smaller increase seen between 2014 and 2015 (median increase in SMR=0.12, range 0.09 
to 0.16). These coincided with ONS recoding of vascular dementia (2010-2011)(18) and 
incentivisation of dementia diagnosis recording in primary care (2014-15)(19). A GAM was 
implemented to assess the trend of SMR across deprivation, by smoothing the non-linear 
relationship seen between year and SMR (Table 1a). This showed that deprivation deciles 4-
10 have a reduced SMR compared to deprivation decile 1, after accounting for year. There 
was stronger statistical evidence of a difference in mortality as the deciles increased, with 
the least deprived having the lowest mean SMR (0.369, 95% CI: 0.338 to 0.400); a decrease 
of 0.159 from decile 1; p < 0.001). In 2017 there were 14,837 excess dementia deaths 
attributable to deprivation (95% CI 13,662 to 16,011). This represented 21.5% of all recorded 
dementia deaths that year (95% CI 19.8% to 23.2%). Results of the Poisson model were 
consistent with the SMR analysis and are shown in Table 2. Decreasing deprivation was 
associated with progressively declining incident risk ratios for dementia mortality (risk ratio 
for least deprived decile 0.75 [95% CI 0.74 to 0.76]). 
 
Association of deprivation with age at death 
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An ordinal logistic regression analysis was implemented to investigate the influence of 
deprivation on the age at death with dementia (Table 1b). This indicated that as deprivation 
decreases, then the odds of dying at an older age increase. For example, the least deprived 
decile had the greatest OR of 1.31 (95% CI: 1.28 to 1.33), indicating that the odds of dying at 
an older age is 31% greater than for the most deprived decile.  
 
Amongst each deprivation decile the proportion of patients dying in each age category was 
examined (Figure 2). This showed that a greater proportion of the most deprived deciles died 
in the younger age groups (e.g. 1.6% of deaths in the most deprived decile occurred in the 
65-69 age group, compared to 1.3% of the least deprived [p<0.001]). This relationship 
persisted up until the 80-84 age group. A higher proportion of dementia deaths in the least 
deprived deciles occurred over the age of 90 (38.8% of the least deprived decile compared to 
33.1% of the most deprived decile).  
 
Association of deprivation with dementia diagnosis 
Decreasing deprivation was associated with a dose-dependent decrease in the odds of having 
an unspecified dementia diagnosis compared to any specified aetiology (Table 1c). For 
example, people from the most affluent areas had 22% lower odds of having an unspecified 




In this study, using routinely collected death certificate diagnoses in England and Wales 
between 2001 to 2017, we demonstrate that greater socioeconomic deprivation is 
associated with higher dementia mortality and this effect appears to be increasing over time. 
These findings add to mounting evidence that socioeconomic status is an important 
determinant of dementia risk(2-6). Although a direct causal relationship between 
socioeconomic status and dementia has yet to be established, stratification of other 
dementia risk factors within more deprived groups would still suggest that deprivation could 
be a major target in public health approaches aimed at reducing the population burden of 
dementia. 
The steadily rising dementia SMR evident in these data despite falling age-specific dementia 
incidence during the same time period is likely to be due to improving ascertainment(16). 
Particularly large year-on-year increases in SMR coincided with known improvements in 
ascertainment related to recoding of vascular dementia by ONS (2011) and incentivisation of 
dementia diagnosis recording in primary care (2015)(18, 19). 
We also found that disparities in dementia mortality according to deprivation increased 
steadily over this time period. This could be because of disproportionately poor 
ascertainment in more deprived populations in earlier years, as a result of which improving 
ascertainment has begun to reveal the true scale of the effect. Of greater public health 
concern would be the alternative explanation that persistent and widening inequality in 
England and Wales is having an increasingly deleterious effect on brain health. Given 
previous findings of increasing excess mortality according to deprivation for other diseases 
in England and Wales, it is likely that the increasing disparities are due to a combination of 
both improved ascertainment and widening inequality(1). 
Being more deprived was associated with younger age at death in those dying from 
dementia. This supports the view that the excess in premature mortality found previously in 
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UK death certificate data is partly due to dementia deaths(1). It also supports previous 
findings that lower socioeconomic status is associated with diagnosis of dementia at a 
younger age and earlier mortality from dementia(10, 20). 
The finding that more deprived deciles were more likely to receive a diagnosis of unspecified 
dementia implies that these groups had poorer access to specialist diagnostic services(17). 
This is consistent with previous evidence showing that more deprived patients access 
services later, and are less likely to be prescribed anti-dementia drugs, implying that they are 
receiving lower quality care(11, 21). These findings raise important challenges for the design of 
memory clinic services in order to ensure equitable access, diagnosis and treatment. From a 
clinical perspective, it is likely that poorer quality of diagnosis in more deprived patients 
means that they are being disadvantaged in terms of prognostication, counselling, planning 
of future care, access to appropriate symptomatic treatments and opportunities to participate 
in research. The under-representation of participants of low socioeconomic status is a key 
challenge for the validity and generalisability of dementia research including clinical trials, 
and ensuring more timely and accurate diagnosis would be an important first step to mitigate 
this. 
The strengths of this work are that it is a large nationwide study that is perfectly 
representative of the population. Moreover, the ability to adjust for the surviving population 
size in each deprivation decile and age group made it possible to mitigate against survival 
effects to some extent, because while those in more deprived deciles are likely to die 
prematurely, their risk of dying from dementia is higher in those surviving. This is evident 
when comparing the trends for numbers of dementia deaths in each IMD decile (which are 
highest in decile 6, and similar in deciles 1 and 10; see Supplementary Table 2) to the trend 
of SMR after adjusting for surviving population size, which is highest in more deprived 
deciles. These aspects are likely to explain why we found important effects of deprivation on 
mortality and age at death when these were not previously detected in a UK population 
study over a similar time period(13).  
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There are important limitations to the current study. Chief among these is the ascertainment 
of dementia through coding in death certificates. This is likely to have high positive predictive 
value for all-cause dementia, but lower positive predictive value for specific dementia 
subtypes, and is likely to lead to incomplete ascertainment of dementia cases(22). It is 
noteworthy, however, that improved ascertainment over time appears to have enhanced the 
size of the effect, suggesting that incomplete ascertainment would tend to bias towards the 
null in this study. It is possible that the effect of deprivation on quality of diagnosis is partly 
due to variation in the standard of death certificate completion rather than diagnosis during 
life. Although we were able to adjust for surviving population size, this does not completely 
correct for survival bias. In particular, those with premature mortality from other causes are 
likely to have comorbidities that increase dementia risk, and would therefore be more likely 
to develop dementia in later years than the background population. It is possible therefore 
that even in this very comprehensive dataset, the effect of deprivation is underestimated. 
Another major limitation is the use of an area-based summary measure of deprivation. This 
does not allow any inferences to be made about which aspects of deprivation are mediating 
the effects. In particular, it is possible that deprivation here is simply serving as a proxy for 
lower educational attainment, which is known to be an important determinant of dementia 
risk(23). However, recent evidence suggests that the reverse may be true, i.e. that education 
acts as a proxy for deprivation more generally in studies on dementia risk (9, 24, 25). Moreover, 
the evidence for an influence of low education principally relates to having no secondary 
level education or being illiterate(8, 26). Secondary education has been compulsory in England 
and Wales since the Fisher Act of 1918 and literacy rates in the United Kingdom are around 
99%, hence it is unlikely that the large effects seen here could be attributable to a very small 
proportion of the population who were illiterate or had no secondary education. Finally, with 
these data, we are unable to account for changing socioeconomic status over time, or for 
internal migration, and therefore we are unable to assess when in the life course deprivation 
is mediating the observed effects. This may be important, as previous work has suggested 
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both cumulative effects across the life course and differential effects at different ages, with 
cognitive decline most strongly linked to wealth in later life(27, 28). 
Future work should focus on addressing the issues of under-representation and survival bias 
in well-phenotyped cohorts that allow for more detailed analysis of the factors mediating the 
influence of deprivation on risk of dementia. Important outstanding questions include 
clarifying which aspects of deprivation are having the most important effects, when in the life 
course these effects are occurring, and how the effects are mediated. Whereas some 
studies have suggested that cognitive reserve is the most important mediator of increased 
dementia risk(29), others have suggested that the effect is mediated by other modifiable risk 
factors, especially vascular risk(24). Other suggested links between socioeconomic status and 
dementia outcomes such as stress, diet and air pollution have not been comprehensively 
evaluated as mediators(7). A more complete understanding of these issues will allow for the 
design of public health interventions that target the most deleterious components of 
deprivation at the appropriate time in life with a view to preventing future dementia.  
 
Conclusions 
Socioeconomic deprivation in England and Wales is associated with higher mortality from 
dementia, younger age at death with dementia and poorer quality of diagnosis. This 
suggests that political failures to combat persistent and widening socioeconomic inequality in 
the UK might be contributing to the rising tide of dementia. In the context of enormous and 
growing societal costs of dementia, and the failure of disease modifying therapies, there 
should be added impetus to address deprivation with a view to promoting lifelong brain 
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 a) b) c) 
IMD decile: Mean SMR (95% CI) OR of being in an 
older age group at 
death (95% CI) 
OR of ‘Unspecified 
dementia’ versus any 
specified (95% CI) 









 Least deprived - 10 
0.528 (0.506, 0.550) 
0.541 (0.510, 0.572) 
0.531 (0.500, 0.562) 
0.493 (0.462, 0.524) 
0.481 (0.450, 0.512) 
0.480 (0.450, 0.512) 
0.455 (0.424, 0.486) 
0.440 (0.409, 0.471) 
0.425 (0.394, 0.456) 
0.369 (0.338, 0.400) 
1 
1.10 (1.08, 1.13) 
1.13 (1.10, 1.15) 
1.16 (1.14, 1.19) 
1.24 (1.22, 1.27) 
1.27 (1.24, 1.30) 
1.26 (1.24, 1.29) 
1.29 (1.26, 1.32) 
1.28 (1.25, 1.31) 
1.31 (1.28, 1.33) 
1 
0.98 (0.95, 1.00) 
0.97 (0.95, 1.00) 
0.96 (0.94, 0.99) 
0.91 (0.89, 0.94) 
0.87 (0.85, 0.89) 
0.83 (0.81, 0.85) 
0.82 (0.80, 0.84) 
0.81 (0.79, 0.83) 
0.78 (0.76, 0.80) 
 
Table 1 The association of deprivation with dementia mortality, age at death and quality 
of diagnosis 
The table shows a) standardised mortality ratio for dementia in each IMD decile (averaged 
across years 2001-2017), b) odds ratios of being in any older age group at time of death from 
dementia for each IMD decile relative to decile 1 and c) odds ratios of receiving a diagnosis of 
unspecified dementia in each IMD decile relative to decile 1 
CI, confidence interval; IMD, Index of Multiple Deprivation; OR, odds ratio; SMR, standardised 
mortality ratio 
 
Factor Incident risk ratio (95% CI)
 for dementia deaths 
Age: 
    65-69 
    70-74 
    75-79 
    80-84 
    85-89 
    90+ 
 
1 
3.10 (3.02, 3.18) 
9.71 (9.48, 9.94) 
27.70 (27.08, 28.33) 
70.91 (69.35, 72.50) 
170.82 (167.08, 174.64) 
IMD decile: 
  Most deprived - 1 
    2 
    3 
    4 
    5 
    6 
    7 
    8 
    9 




0.97 (0.96, 0.98) 
0.91 (0.90, 0.92) 
0.90 (0.89, 0.91) 
0.91 (0.90, 0.92) 
0.88 (0.87, 0.89) 
0.86 (0.85, 0.87) 
0.84 (0.83, 0.85) 
0.75 (0.74, 0.76) 
Table 2 The association of age and deprivation with incident risk of dying from 
dementia. The table shows incident risk ratios for death from dementia derived from the 
Poisson model with person-years of exposure as the offset. 




Figure 1: Standardised Mortality Ratios for IMD deciles over time.  
The figure shows SMRs for each IMD decile for population aged 65 or above in England and 
Wales, with IMD decile 1 in 2017 as the reference category. Shaded areas represent 95% 
confidence intervals for SMR estimates. 
IMD, Index of Multiple Deprivation. 
 
 
Figure 2: The association of deprivation with age at death from dementia. 
A: Odds ratios (95% CI) of dying in an older age group according to IMD decile among those 
who died of dementia aged over 65 in England and Wales between 2001 and 2017. 
B: Percentage of dementia deaths within each IMD decile occurring in each age group in 
England and Wales 2001-2017 






Figure 1: Standardised Mortality Ratios for IMD deciles over time.  
The figure shows SMRs for each IMD decile for population aged 65 or above in England and 
Wales, with IMD decile 1 in 2017 as the reference category. Shaded areas represent 95% 
confidence intervals for SMR estimates. 
IMD, Index of Multiple Deprivation. 
 
 
Figure 2: The association of deprivation with age at death from dementia. 
A: Odds ratios (95% CI) of dying in an older age group according to IMD decile among those 
who died of dementia aged over 65 in England and Wales between 2001 and 2017. 
B: Percentage of dementia deaths within each IMD decile occurring in each age group in 
England and Wales 2001-2017 
IMD, Index of Multiple Deprivation 






coding Description of coding 
F01 Vascular dementia 
F01.0 Vascular dementia of acute onset 
F01.1 Multi-infarct dementia 
F01.2 Subcortical vascular dementia 
F01.3 Mixed cortical and subcortical vascular dementia 
F01.8 Other vascular dementia 
F01.9 Vascular dementia, unspecified 
F03 Unspecified dementia F03 Unspecified dementia 
G30 Alzheimer’s disease 
F00.0/G30.0 Dementia in Alzheimer disease with early onset 
F00.1/G30.1 Dementia in Alzheimer disease with late onset 
F00.2/G30.8 Dementia in Alzheimer disease, atypical or mixed 
type 








F02.0 Dementia in Pick disease 
F02.1 Dementia in Creutzfeldt-Jakob disease 
F02.2 Dementia in Huntington disease 
F02.3 Dementia in Parkinson disease 
F02.4 Dementia in human immunodeficiency virus [HIV] 
disease 
F02.8 Dementia in other specified diseases classified 
elsewhere 
G31.0 Circumscribed brain atrophy 
G31.1 Senile degeneration of brain, not elsewhere classified 
G31.2 Degeneration of nervous system due to alcohol 
G31.8 Other specified degenerative diseases of nervous 
system 
G31.9 Degenerative disease of nervous system, unspecified 
The table shows ICD 10 diagnostic codes for dementia, along with their grouping by ONS into the 
broader diagnostic categories used in the analysis. 
  
Supplementary Table 2: Numbers of dementia deaths by year, IMD decile, diagnostic category and 































c) Dementia Type 
Vascular Dementia (F01) 77,165 
Unspecified Dementia (F03) 351,438 
Mild Cognitive impairment (F06.7) 37 
Alzheimer’s disease (G30) 137,477 
Other degenerative diseases of nervous 










The table shows the distribution of total number of dementia deaths recorded across the four 
categories: a) Year; b) IMD decile; c) diagnostic category; and d) Age-group. The factors with the 
greatest number of deaths recorded for a given category, is highlighted in bold. 
 
